why choose us

First received: June 28, 2023

Clinical Trial: A Study Evaluating the Pharmacokinetics and Relative Bioavailability of Emraclidine Immediate-Release Tablets in Healthy Adult Participants

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Healthy Participants

Study Type: INTERVENTIONAL


Official Title: A Phase 1, Open-label Trial to Evaluate the Pharmacokinetics and Relative Bioavailability of Emraclidine Following a Single Oral Administration of Immediate-Release Tablets in Healthy Adult Participan

Brief Summary: The purpose of this trial is to evaluate plasma concentrations of emraclidine following single dose oral administration of different emraclidine immediate release (IR) tablets in healthy participants.

Read more